Precigen Inc. (NASDAQ:PGEN) saw an upside of 4.31% to $1.21 after adding $0.05 on Wednesday. The 5-day average trading volume is 1,149,603 shares of the company’s common stock. It has gained $1.3200 in the past week and touched a new high 2 times within the past 5 days. An average of 1,250,626 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,302,726.
PGEN’s 1-month performance is 4.31% or $0.0850 on its low of $1.0600 reached on 08/07/23. The company’s shares have touched a 52-week low of $0.81 and high of $2.90, with the stock’s rally to the 52-week high happening on 01/23/23. YTD, PGEN has lost -20.39% or -$0.3250 and has reached a new high 10 times. However, the current price is down -58.28% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
PGEN stock investors last saw insider trading activity on Aug 04.Sabzevari Helen (President and CEO) most recently sold 52,870 shares at $1.10 per share on Aug 04. This transaction cost the insider $58,157. Chief Legal Officer, Lehr Donald P., sold 10,821 shares at a price of $1.20 on Aug 03. Then, on Aug 03, SVP, IP Affairs Perez Jeffrey Thomas sold 8,789 shares at a price of $1.20 per share. This transaction amounted to $10,547.
Valuation Metrics
PGEN stock has a beta of 1.95. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 13.44 while the price-to-book (PB) in the most recent quarter is 1.51.
In terms of profitability, the gross margin trailing 12 months is 73.50%. The trailing 12-month EBITDA margin is -250.53%. The firm’s gross profit as reported stood at $20.57 million against revenue of $26.91 million.
Earnings Surprise
For the quarterly period ending March 30 this year, Precigen Inc.’s cash and short-term investments amounted to $94.35 million against total debt of $21.69 million. Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 15.31% to -$22.73 million, while revenue of -$22.18 million was 2.42% off the previous quarter. Analysts expected PGEN to announce -$0.09 per share in earnings in its latest quarter, but it posted -$0.1, representing a -11.10% surprise. EBITDA for the quarter stood at more than -$21.94 million. PGEN stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 57.41 million, with total debt at $21.69 million. Shareholders hold equity totaling $255.48 million.
Let’s look briefly at Precigen Inc. (PGEN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 08 August was 47.11% to suggest the stock is trending Neutral, with historical volatility in this time period at 87.11%.
The stock’s 5-day moving average is $1.1450, reflecting a -0.42% or -$0.0050 change from its current price. PGEN is currently trading +3.02% above its 20-day SMA, +10.65% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -2.05% and SMA200 by-30.52%.
Stochastic %K and %D was 26.33% and 16.59% and the average true range (ATR) pointed at 0.1008. The RSI (14) points at 48.02%, while the 14-day stochastic is at 36.00% with the period’s ATR at 0.0988. The stock’s 9-day MACD Oscillator is pointing at -0.0556 and -0.0750 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Precigen Inc. (NASDAQ: PGEN), JP Morgan launched coverage with a Neutral rating. Analysts offering their rating for PGEN stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate PGEN as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 4 have offered a “buy” rating.
What is PGEN’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $6.00 and a high of $14.00, with their median price target at $8.15. Looking at these predictions, the average price target given by analysts is for Precigen Inc. (PGEN) stock is $9.07.
